Fundraising FoxNumbcorp
1 known investors
Find your way into Numbcorp
Sign up to see every warm intro you have to Numbcorp
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Numbcorp team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Numb Corp develops TRPV1-targeted, botulinum-derived biologics that selectively enter sensory neurons to produce prolonged local inhibition of neurotransmission, aiming to deliver durable regional pain control. Its therapeutics are designed to be locally administered to control pain near its source while avoiding the systemic exposure associated with conventional pain medicines, including opioids.
Founders & leadership
Investors · 1
Frequently asked questions
- What does Numbcorp do?
- Numb Corp develops TRPV1-targeted, botulinum-derived biologics that selectively enter sensory neurons to produce prolonged local inhibition of neurotransmission, aiming to deliver durable regional pain control. Its therapeutics are designed to be locally administered to control pain near its source while avoiding the systemic exposure associated with conventional pain medicines, including opioids.
- Who are Numbcorp's investors?
- Numbcorp's investors include StartX.